{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-008923","form_type":"8-K","ticker":"GAMG","cik":"0000055234","company_name":"Global Asset Management Group, Inc.","filed_at":"2023-12-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.724920+00:00","generated_at":"2026-06-07T19:02:04.627079+00:00","sec_items":["2.01","3.02","5.01","5.02","5.06","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Kenilworth Systems acquires 60% of Regenecell; pivots to medical travel referral","bullets":["Issued 2M shares (3.8% of outstanding) to acquire 60% of Regenecell, a Florida medical travel consulting firm.","Regenecell founder Steven Swank retains 40% minority interest and serves as officer of the subsidiary.","Company had no operating revenue since 1998; acquisition ends shell status and establishes operating business.","Net loss of $126,906 for nine months ended Sept. 30, 2023; no revenue from operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-008923","json":"https://secwatch.observer/filing/0001477932-23-008923.json","markdown":"https://secwatch.observer/filing/0001477932-23-008923.md","text":"https://secwatch.observer/filing/0001477932-23-008923.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/55234/000147793223008923/0001477932-23-008923-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/55234/000147793223008923/kens_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T19:02:04.627079+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a6fa1947086037231f51ab54a9e3c1d750944c44","claim":"Global Asset Management Group, Inc.: The registrant ceased being a shell company upon completion of a share exchange transaction.","evidence_excerpt":"As a result of the completion of the share exchange transaction described in Item 2.01 (Completion of Acquisition or Disposition of Assets) of this current report on Form 8-K, which is incorporated herein in its entirety, we ceased being a “shell company,” as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/55234/000147793223008923/0001477932-23-008923-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"shell status"}],"fact_type":"governance_change"},{"claim_id":"7a821d2817e47136741bbb296c59e5f7be6164d3","claim":"Global Asset Management Group, Inc. completed an acquisition involving Regenecell, Inc. (closed 2023-09-30).","evidence_excerpt":"we acquired 60% of the issued and outstanding Common Stock of Regenecell, Inc.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/55234/000147793223008923/0001477932-23-008923-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Regenecell, Inc."},{"label":"Closing","value":"2023-09-30"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}